Anita Garg, MS
Ms. Garg is responsible for developing IPM’s integrated programmatic and financial strategic plans, leading business development activities and implementing new strategic initiatives. She currently leads a cross-functional team aimed at licensing and rolling out IPM’s monthly dapivirine vaginal ring in developing countries and other low-resource settings. Over more than 15 years at IPM, Ms. Garg has provided key project and program management and strategy support to IPM’s monthly dapivirine vaginal ring, from early formulation development to initial market introduction.
Prior to joining IPM, Ms. Garg worked as a biologist and program analyst at the US National Institutes of Health’s Vaccine Research Center on the development of new vaccine candidates for HIV, Ebola, SARS and other viruses.
Ms. Garg holds a bachelor’s degree in biology and genetics from the University of Maryland (honors program) and a master's degree in biotechnology from Johns Hopkins University.